Aspen Lung Conference: Rebuilding the Injured Lung
阿斯彭肺会议:重建受伤的肺
基本信息
- 批准号:8711900
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAddressAdult Respiratory Distress SyndromeAlveolarCellsClinicalClinical InvestigatorClinical Trials DesignCollaborationsComplexConnective TissueDevelopmentEpithelial CellsFibrosisFosteringGenerationsGoalsInjuryInternationalKnowledgeLeadLungLung InflammationLung diseasesMediatingMesenchymalPatient CarePatientsPerformancePulmonary FibrosisResearchResearch PersonnelScientific Advances and AccomplishmentsScientistSeriesStem cellsTranslatingTranslationsextracellularimprovedinjuredinterestlung injurylung repairmeetingsnovel strategiespre-clinicalpreventprogramspublic health relevancerepairedscaffoldstem cell biologysuccesssymposium
项目摘要
DESCRIPTION (provided by applicant): With an emphasis on the integration of basic, translational and clinical approaches, the 57th annual Thomas L. Petty Aspen Lung Conference will focus on a central question: how can we translate knowledge regarding the mechanisms underlying alveolar injury into effective approaches to rebuild the injured lung? To address this central question, we have organized the conference program into a series of thematic sessions focusing on (i) contemporary understanding of the pathogenic mechanisms underlying acute and progressive lung injury and fibrosis, (ii) conceptual issues centering around the complex interactions between pulmonary epithelial cells, mesenchymal cells, and the surrounding extracellular connective tissue matrix, (iii) current understanding of matrix scaffolds and stem cell biology as approaches to repairing and rebuilding the injured lung, while preventing the development or progression of fibrotic lung disease, and (iv) strategies to translate scientific advances into potential therapies for patients with lung injury and/or fibrosis. By addressing these topics across six thematic sessions, we seek to accomplish the following objectives: 1) To provide an international forum for leading basic, translational, and clinical researchers to exchange ideas regarding fundamental concepts contributing to lung injury, fibrosis, and repair. 2) To stimulate interactions between the historically-disparate scientific fields of Acute Lung Injury/ARDS and Pulmonary Fibrosis with the goal of identifying emerging, shared interests that may lead to the performance of more efficient and productive research. 3) To enhance the likelihood of success in translation of preclinical scientific advances into direct patient benefit by developing novel strategies to better implement scientific advances into patient care and by addressing challenges in clinical trial design. 4) To challenge and stimulate the scientific interests of trainees, attracting a new generation of junior investigators into the fields of lung injury and repair.
描述(由申请人提供):第57届年度托马斯L。Petty白杨肺会议将集中讨论一个中心问题:我们如何将肺泡损伤机制的知识转化为重建受损肺的有效方法?为了解决这个中心问题,我们将会议计划组织成一系列主题会议,重点是(i)对急性和进行性肺损伤和纤维化的致病机制的当代理解,(ii)围绕肺上皮细胞,间充质细胞和周围细胞外结缔组织基质之间复杂相互作用的概念问题,(iii)目前对基质支架和干细胞生物学的理解,作为修复和重建受损肺的方法,同时防止纤维化肺病的发展或进展,以及(iv)将科学进步转化为肺损伤和/或纤维化患者的潜在疗法的策略。通过在六个专题会议中讨论这些主题,我们寻求实现以下目标:1)为领先的基础,转化和临床研究人员提供一个国际论坛,以交流有关肺损伤,纤维化和修复的基本概念的想法。2)刺激急性肺损伤/ARDS和肺纤维化的历史不同的科学领域之间的互动,以确定新兴的,共同的利益,可能导致更有效和富有成效的研究性能的目标。3)通过制定新的策略,更好地将科学进步应用于患者护理,并解决临床试验设计中的挑战,提高临床前科学进步成功转化为直接患者受益的可能性。4)挑战和激发学员的科学兴趣,吸引新一代的初级研究人员进入肺损伤和修复领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David W. Riches其他文献
David W. Riches的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David W. Riches', 18)}}的其他基金
Targeting early events in MUC5B-driven lung injury and fibrosis
针对 MUC5B 驱动的肺损伤和纤维化的早期事件
- 批准号:
10627600 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema
肺泡间隔成纤维细胞丢失与肺气肿的发病机制
- 批准号:
10609797 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Alveolar Septal Fibroblast Loss and The Pathogenesis of Emphysema
肺泡间隔成纤维细胞丢失与肺气肿的发病机制
- 批准号:
10367957 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
Therapeutic Targeting of PTPN13 in Idiopathic Pulmonary Fibrosis
PTPN13 在特发性肺纤维化中的治疗靶向
- 批准号:
9142965 - 财政年份:2017
- 资助金额:
$ 2万 - 项目类别:
DUSP1 as a therapeutic target in fibroproliferative acute lung injury
DUSP1作为纤维增殖性急性肺损伤的治疗靶点
- 批准号:
8503966 - 财政年份:2013
- 资助金额:
$ 2万 - 项目类别:
Initial functional characterization of TRUSS-deficient mice
TRUSS 缺陷小鼠的初步功能表征
- 批准号:
8511974 - 财政年份:2013
- 资助金额:
$ 2万 - 项目类别:
Initial functional characterization of TRUSS-deficient mice
TRUSS 缺陷小鼠的初步功能表征
- 批准号:
8649023 - 财政年份:2013
- 资助金额:
$ 2万 - 项目类别:
DUSP1 as a therapeutic target in fibroproliferative acute lung injury
DUSP1作为纤维增殖性急性肺损伤的治疗靶点
- 批准号:
8665478 - 财政年份:2013
- 资助金额:
$ 2万 - 项目类别:
DUSP1 as a therapeutic target in fibroproliferative acute lung injury
DUSP1作为纤维增殖性急性肺损伤的治疗靶点
- 批准号:
9066180 - 财政年份:2013
- 资助金额:
$ 2万 - 项目类别:
Lung specific TNF-R1 signaling in TRUSS null mice
TRUSS 无效小鼠的肺特异性 TNF-R1 信号传导
- 批准号:
7496933 - 财政年份:2007
- 资助金额:
$ 2万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 2万 - 项目类别:














{{item.name}}会员




